Featured Articles in the Current Issue
Rationale, motivation, and considerations for combining surgeries.
A new treatment paradigm benefits patients with juvenile glaucoma.
A valuable tool to optimize intervention and follow-up.
A potential noninvasive therapy for mild-to-moderate cases.
A conversation with Brian Flowers, MD
Departments and Columns
Glaucoma News Briefs
- Nicox NO-Donating Analog Effective in Phase 2 Trial
- Santen MicroShunt vs Trabeculectomy at 1 Year
- Allergan Recalls Xen 45 Glaucoma Device
- Glaukos Enrolls Patients in iStent Infinite Trial
- Nicotinamide May Prevent Damage From Glaucoma
- New Ahmed Valveless Drainage Device Introduced
- Glaucoma Survey Highlights Patients’ Concerns
- MST Acquires Trabectome Glaucoma Surgery Platform
- Glaukos Says iStent inject Data Superior to iStent
- OMNI Surgical System Effective in Pilot Study
- Sensor for Continuous IOP Monitoring
- Annexon Drug Shows Neuroprotective Effects
- Better Images of the Trabecular Meshwork
- OMNI System Effective With Cataract Surgery